A detailed history of Lmr Partners LLP transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Lmr Partners LLP holds 35,300 shares of ORIC stock, worth $345,940. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,300
Holding current value
$345,940
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$5.58 - $12.54 $196,974 - $442,661
35,300 New
35,300 $196,000
Q1 2023

May 15, 2023

BUY
$4.26 - $6.75 $101,302 - $160,515
23,780 New
23,780 $135,000
Q2 2022

Aug 15, 2022

BUY
$2.7 - $7.07 $30,447 - $79,728
11,277 New
11,277 $51,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $388M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.